Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives
Crossref DOI link: https://doi.org/10.1007/s00277-016-2617-y
Published Online: 2016-02-19
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Malagola, Michele
Papayannidis, Cristina
Baccarani, Michele
Text and Data Mining valid from 2016-02-19